Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-060787

SVP, COO & CFO acquired 40,150 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Labrucherie Gil M SVP, COO & CFO 2019-12-12 Grant or award +40,150 259,159 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Labrucherie Gil M SVP, COO & CFO 2019-12-12 Grant or award · Stock Option +71,550 71,550 D: show line 2 in the form
Labrucherie Gil M SVP, COO & CFO 2019-12-12 Grant or award · Stock Option +29,000 29,000 D: show line 3 in the form
Loading xslF345X03/doc4.xml…